This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Dr. Jacob Guo, PhD
Director of Nucleic Acid R&D Platform at GenScript
Speaker

Profile

Dr. Jacob (Chun) Guo is currently the Director of the Nucleic Acid R&D Platform in GenScript’s Life Science Group. Jacob got his PhD in Chemistry from the University of Georgia, with expertise in nucleic acid chemistry and oligonucleotide modifications. He published 5 scientific papers as the first author in peer-reviewed high-impact factor journals and submitted multiple patents related to the bioconjugation of oligonucleotides, applying oligonucleotides in diagnostic scenarios. He has 10+ years of experience in solid-phase synthesis of oligonucleotides. His recent research focuses on manufacturing and quality control for synthetic long oligonucleotides.

Agenda Sessions

  • Harnessing RNA to Simplify and Advance Gene Therapy

    7:45am